Opinion Volume 6 Issue 2
1Azienda Ospedaliera San Camillo Forlanini, Italy
2Universita degli Studi di Roma La Sapienza, Dipartimento di Urologia, Italy
3Institute of Molecular Biology and Pathology, Italian National Research Council (CNR-IBPM), Italy
Correspondence: Andrea Zangari, Azienda Ospedaliera San Camillo Forlanini, Roma, Italy, piazza Carlo Forlanini, 4, Roma, Italy, Tel 393000000000, Fax 391000000000
Received: January 30, 2016 | Published: February 7, 2017
Citation: Indications To Surgery In Necrotising Enterocolitis Of Extremely Low Birth Weight Prematures. Can We Do Better? J Pediatr Neonatal Care 6(2): 00237. DOI: 10.15406/jpnc.2017.06.00237
A Disease of the premature
Low birth weight prematures are affected by multiple function immaturity that influence survival and outcome. Although increased understanding of physiology and technology advancements have decreased mortality, still survival is directly related to birth weight.
Extremely low birth weight infant (ELBW) (< 1000grams) remain at high risk for death and disability with 30–50% mortality and at least 20–50% risk of morbidity in survivors.
Survival of these high risk patients has been reported to be 20% when birth weight is between 500 and 600g, with a 50% incidence of significant neurodevelopmental impairment in 500-750g infants1 Due to this weight related risk, some authors even defined as incredibly low birth weight (ILBW) a subset of patients whose birth weight is less than 750gm, although a systematic characterization of such a group is lacking.2,3
Necrotising enterocolitis is one of the major complications affecting these patients, often leading to an unfavorable outcome despite surgical treatment, because of intestinal necrosis and sepsis. Early stages of NEC are treated conservatively, but understanding progression of the disease and optimal timing of surgery is often challenging.
The indications for surgery include the presence of pneumoperitoneum, indicating perforation of the intestine, clinical deterioration despite maximal medical treatment, abdominal mass with intestinal obstruction, and development of intestinal stricture. Relative indications include fixed dilated intestinal loop, presence of portal gas, thrombocytopenia, and rapid fall in platelet count.4,5
Although relative indications to surgery may apply, the absolute indication to surgery in prematures with NEC is Bell stage III, which is characterized by the aforementioned clinical features of advanced disease and progressive deterioration. This condition involves high fatality. Patients who undergo surgery are more likely to die than the ones who do not.#ref66
Gangrene and perforation are known to be associated with 30% and 64% postoperative mortality rate respectively7 and the outcome of affected infants is influenced by the length of necrotic bowel.8
Surgery most commonly consists of laparotomy, resection of the necrotic bowel and ileostomy. Different surgical techniques such as diverting jejunostomy or ‘clip and drop’ have been described to deal with extensive disease and avoid massive small bowel resection, while survival seems not to be affected by laparotomy compared to peritoneal drainage. The advantage of resection and primary anastomosis over stoma formation is still controversial.9 Although prospective studies and randomized controlled trials are needed to define the best operative treatment for neonates with severe NEC, resection with ileostomy is the most frequently used procedure.9−11
Enterostomy has always played a consistent role in the surgical treatment of NEC, with the purpose of decompression and protection of questionable bowel from further damage.12 Yet it is usually performed in association with resection of necrotic bowel when current indications for surgery are encountered, that is in advanced stages of the disease. Although it has rarely been investigated for potential benefits as an isolated procedure, it resulted in statistically significant improvement of survival, especially in low- and extremely low birth weight patients13,14 and it has been shown to prevent progression of disease at earlier stages.15−17
Extremely low birth-weight (ELBW), premature infants who develop necrotizing enterocolitis (NEC) or isolated intestinal perforation (IP) represent a group of patients with extremely high morbidity and mortality. ELBW refers specifically to infants with birth weight <1000 g. Multiple case series report the mortality of ELBW infants that undergo operation for NEC to be approximately 50%.11,18,19
In VLBW infants with NEC, surgery has not been found to directly correlate with mortality, yet this was associated with extensive intestinal involvement and/or advanced disease. In an appropriate setting, operative intervention under general anesthesia has been shown to be well tolerated by VLBW infants with NEC, independently from birth weight and G.A.20
Due to anaesthesiological and surgical risk concerns, standard indications are usually delayed to the life-threatening condition of advanced disease, which includes perforation and clinical deterioration. A more timely surgical intervention may be defined by panels describing the trajectory of metabolic derangement.21 Nonetheless, according to some authors, early primary laparotomy is safe and effective in ELBW infants and survival seems to be affected by the length of necrotic bowel rather than by surgery itself or by age and weight at surgery.8,22
While novel forms of treatment, including whole-body moderately controlled hypothermia and administration of amniotic fluid stem cells, are currently under investigation,23 the surgeon is facing with increasingly fragile patients who survive premature birth. In the light of the previous considerations, new attention should be focused on the possible role of surgery in preventive measures, in high risk selected cases, in which waiting for free air may be too late.21 Although standard indications to surgery for NEC still rely on signs of advanced disease, it can be reasonably hypothesized that in selected extremely challenging situations as ELBW or ILBW, laparotomy and enterostomy at an earlier stage than usual may be worth of new consideration, in order to prevent further progression of disease, which seems to directly correlate with mortality rather than surgery itself. New randomized studies on this challenging matter are warranted to achieve the basis of a new perspective of current surgical indications for NEC.
None.
Author declares there are no conflicts of interest.
None.
©2017 Indications, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.